ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Using the biopolymer heparin and a nanofiber scaffold, researchers at Northwestern University have developed a novel nanostructure that promotes blood vessel growth (Nano Lett., DOI: 10.1021/nl0613555). The system, developed by Samuel I. Stupp and his colleagues, could become an important tool in regenerative medicine, where new blood vessel formation is critical for healing wounds.
The nanofiber's basic building block is a peptide amphiphile that has a hydrocarbon chain on one end and a polypeptide designed to bind heparin on the other. In the presence of heparin, these chainlike molecules assemble into cylindrical fibers with the hydrocarbon chains at the core and the peptide-heparin complex at the surface. When combined with nanogram amounts of angiogenic growth factors known to interact with heparin, the nanostructures stimulate extensive new blood vessel formation in vivo.
Stupp thinks the nanostructure's defined shape and surface account for its remarkable angiogenic properties. Preliminary experiments to treat skin wounds in rabbits and damaged heart tissue in mice have "shown promising results," he says.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X